Yu J, Langridge WH
Center for Molecular Biology and Gene Therapy, Department of Biochemistry, School of Medicine, Loma Linda University, Loma Linda, CA 92359, USA.
Curr Infect Dis Rep. 2000 Feb;2(1):73-77. doi: 10.1007/s11908-000-0091-z.
Advances in genetic engineering in the past decade have accelerated the expression, in plants, of foreign proteins with industrial and pharmaceutical value. Antigens from infectious bacterial or viral diseases have been introduced into plants through plant virus-mediated infection or Agrobacterium tumefaciens-mediated stable transformation methods. Oral immunization with transgenic plant tissues that contain vaccine antigen proteins stimulates both systemic and mucosal immune responses in animals. Plant-based vaccines can provide significant levels of protection against challenge by viral or bacterial pathogens.
过去十年基因工程的进展加速了具有工业和药用价值的外源蛋白在植物中的表达。传染性细菌或病毒疾病的抗原已通过植物病毒介导的感染或根癌农杆菌介导的稳定转化方法导入植物。用含有疫苗抗原蛋白的转基因植物组织进行口服免疫可刺激动物的全身和黏膜免疫反应。基于植物的疫苗能提供高水平的保护,抵御病毒或细菌病原体的攻击。